| Period | Net Revenue | Cost of Revenue | Net Profit | EPS |
|---|---|---|---|---|
| FY2022 | 2.61B |
1.49B | 2.61B |
$3.05 |
| Q32022 |
666.73M
+2.3%
|
378.15M |
71.1M
-11.2%
|
$0.79 |
| Q22022 |
651.72M
+5.7%
|
364.41M |
80.08M
+31.6%
|
$0.89 |
| Q12022 |
616.65M
|
359.46M |
60.84M |
$0.68 |
| FY2021 | 2.31B |
0 | 195.56M |
$2.15 |
| Q42021 |
593.48M
+1%
|
0 |
75.21M
+13.7%
|
$0.79 |
| Q32021 |
587.56M
+0.9%
|
332.86M |
66.13M
+48.6%
|
$0.74 |
| Q22021 |
582.16M
+5.6%
|
331.87M |
44.51M
+358.1%
|
$0.5 |
| Q12021 |
551.2M
|
325.66M |
9.72M |
$0.11 |
| FY2020 | 2.09B |
1.24B | -672.13M |
$-7.65 |
| FY2019 | 3.11B |
123.06M | 108.92M |
$1.24 |
| FY2018 | 3.01B |
119.31M | -175.75M |
$-2.01 |
| Period | Total Assets | Total Liabilities | Cash & Eq. | Debt | Stock Equity |
|---|---|---|---|---|---|
| FY2022 | 4.99B |
2.09B | 97.65M |
1.58B |
2.81B |
| Q32022 | 4.94B |
2.11B | 93.42M |
1.54B |
2.74B |
| Q22022 | 4.88B |
2.14B | 128.37M |
1.55B |
2.66B |
| Q12022 | 4.83B |
2.19B | 140.37M |
1.63B |
2.57B |
| FY2021 | 4.77B |
2.19B | 133.81M |
1.74B |
2.52B |
| FY2020 | 6.5B |
4.6B | 378.7M |
3.46B |
1.9B |
| FY2019 | 6.88B |
4.34B | 124.19M |
3.26B |
2.51B |
| FY2018 | 6.17B |
3.81B | 50.51M |
3.23B |
2.33B |
| Period | Operating CF | Investing CF | Financing CF | Capex | Free Cash Flow |
|---|---|---|---|---|---|
| FY 2022 | 380.57M |
-305.83M | -110.9M |
-296.15M |
84.42M |
| Q32022 | 41.04M |
-78.02M | 2.04M |
-76.35M |
-35.31M
-152.5%
|
| Q22022 | 149.2M |
-86.09M | -75.11M |
-81.92M |
67.29M
+156.2%
|
| Q12022 | 76.79M |
-49.69M | -20.54M |
-50.53M |
26.26M
|
| FY2021 | 374.22M |
1.02B | -1.64B |
-244.81M |
129.41M |
| FY2020 | 658.81M |
-281.84M | -51.5M |
-216.62M |
442.19M |
| FY2019 | 332.9M |
-201.14M | -61.63M |
-284.68M |
48.22M |
| FY2018 | 414.08M |
-360.96M | -67.33M |
-341.46M |
72.62M |
Halozyme Therapeutics,...
Nutex Health Inc.
Sarepta Therapeutics,...
R1 RCM Inc.
ShockWave Medical, Inc...
Legend Biotech Corpora...
Sotera Health Company
Change Healthcare Inc.